Statistics for Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy
Total visits
| views | |
|---|---|
| Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy | 2 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 1 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| arevalo_intravitreal_2018.pdf | 126 |